Pune, Maharashtra, November 08, 2019 (Wired Release) Prudour Pvt. Ltd. – The global external defibrillator market is estimated to be valued at around US$ 0.05 Bn in 2019 and is expected to register a CAGR of 6.1%. The report offers in-depth insights, revenue details, and other vital information regarding the global external defibrillator market and the various trends, drivers, restraints, opportunities, and threats in the target market till 2027. The report also offers insightful and detailed information regarding the various key players operating in the global external defibrillator market, and their financials, apart from strategies, acquisitions and mergers, and market footprint. The global external defibrillator market is segmented on the basis of product type, end-user, and region.
This report is based on synthesis, analysis, and interpretation of information gathered regarding the target market from various sources. Our analysts have analyzed the information and data and gained insights using a mix of primary and secondary research efforts with the primary objective to provide a holistic view of the market. In addition, an in-house study has been made of the global economic conditions and other economic indicators and factors to assess their respective impact on the market historically, as well as the current impact in order to make informed forecasts about the scenarios in future.
Increasing incidence and prevalence of lifestyle diseases, such as cardiac disorder, resulted into increasing incidence of Non-Communicable Diseases (NCD), coupled with an increasing aging population is expected to bolster demand for treatment of such diseases and conditions over the forecast period. Increasing awareness about the disease and rising demand for treatment of SCA is expected to support the growth of the market over the forecast period.
Manufacturers operating in the target market are focusing towards launching technologically advanced and innovative external defibrillators in order to gain a competitive edge, is also anticipated to propel the demand for cardiovascular devices. In April 2017, Physio-Control, Inc., which is a US-based company develops, manufactures, sales, and services of external defibrillators or monitors, and emergency medical response products and services received US Food and Drug Administration Premarket Approval (PMA) for the company’s HeartSine Samaritan PAD 360P (SAM 360P) – fully automatic external defibrillator for sale in the US.
In April 2014, Boston Scientific Corporation, which is a US-based company develops, manufactures, and markets medical devices for use in various interventional medical specialties – received FDA approval for its latest generation of defibrillators and heart failure devices designed to advance patient care. The newly approved devices include DYNAGEN MINI and INOGEN MINI ICDs, as well as DYNAGEN X4 and INOGEN X4 CRT-Ds.
Public access defibrillation programs deploy automated external defibrillators for bystander use in an emergency situation, reduce time to defibrillation, and improves survival rates which are expected to increase the growth of the global external defibrillators market over the forecast period. On the basis of product type segmentation, the automated external defibrillators segment is expected to contribute major revenue share and is expected to maintain its dominance over the forecast period. The automated external defibrillators segment is expected to witness the highest CAGR of over 6%.
On the basis of end-user segment, the hospital segment is expected to contribute major revenue share and is expected to maintain its dominance over the forecast period. The hospital segment is expected to witness the highest CAGR of over 6% during the forecast period. North America market dominates the target market, owing to increasing incidence of sudden heart attack, coupled with non-invasive nature and increasing demand of home healthcare for the treatment of sudden cardiac arrest among individuals in countries in the region.
Do inquire about this report here: https://ift.tt/2K9o9S0
Key companies operating in the external defibrillator market are Cardiac Science Corporation, Koninklijke Philips N.V., Mindray Medical International Limited, LivaNova PLC, ZOLL Medical Corporation, Nihon Kohden Corporation, Schiller AG and HeartSine Technologies LLC.
from WiredRelease https://ift.tt/2PWRaVg
via gqrds
No comments:
Post a Comment